Schedule 13D ownership disclosure

SCICLONE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80862K104

Event date: 2016-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-767104
Form type
SC 13D/A
Filer
Ally Bridge LB Healthcare Master Fund Ltd
CIK
CIK 1667354
Filed
Nov 14, 2016
Reporting period
Nov 14, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub